Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
ARDT vs CYH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
ARDT vs CYH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $1.41B | $408M |
| Revenue (TTM) | $6.43B | $21.48B |
| Net Income (TTM) | $134M | $-88M |
| Gross Margin | 60.5% | 53.7% |
| Operating Margin | 8.9% | -39.8% |
| Forward P/E | 8.7x | 0.8x |
| Total Debt | $2.26B | $11.58B |
| Cash & Equiv. | $710M | $260M |
ARDT vs CYH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 24 | May 26 | Return |
|---|---|---|---|
| Ardent Health Partn… (ARDT) | 100 | 55.3 | -44.7% |
| Community Health Sy… (CYH) | 100 | 55.0 | -45.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ARDT vs CYH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ARDT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.40
- Rev growth 6.0%, EPS growth -39.2%, 3Y rev CAGR 7.2%
- -38.5% 10Y total return vs CYH's -80.3%
CYH is the clearest fit if your priority is value and momentum.
- Lower P/E (0.8x vs 8.7x)
- -11.7% vs ARDT's -30.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs CYH's -1.2% | |
| Value | Lower P/E (0.8x vs 8.7x) | |
| Quality / Margins | 2.1% margin vs CYH's -0.4% | |
| Stability / Safety | Beta 1.40 vs CYH's 1.60 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -11.7% vs ARDT's -30.5% | |
| Efficiency (ROA) | 2.6% ROA vs CYH's -0.7%, ROIC 7.5% vs -70.1% |
ARDT vs CYH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ARDT vs CYH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ARDT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CYH is the larger business by revenue, generating $21.5B annually — 3.3x ARDT's $6.4B. Profitability is closely matched — net margins range from 2.1% (ARDT) to -0.4% (CYH). On growth, CYH holds the edge at +2.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6.4B | $21.5B |
| EBITDAEarnings before interest/tax | $733M | -$7.8B |
| Net IncomeAfter-tax profit | $134M | -$88M |
| Free Cash FlowCash after capex | $214M | -$200M |
| Gross MarginGross profit ÷ Revenue | +60.5% | +53.7% |
| Operating MarginEBIT ÷ Revenue | +8.9% | -39.8% |
| Net MarginNet income ÷ Revenue | +2.1% | -0.4% |
| FCF MarginFCF ÷ Revenue | +3.3% | -0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.0% | +2.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.4% | -45.2% |
Valuation Metrics
CYH leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
At 0.8x trailing earnings, CYH trades at a 93% valuation discount to ARDT's 10.3x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.4B | $408M |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $11.7B |
| Trailing P/EPrice ÷ TTM EPS | 10.29x | 0.77x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.65x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 6.17x | — |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 0.03x |
| Price / BookPrice ÷ Book value/share | 0.83x | — |
| Price / FCFMarket cap ÷ FCF | 5.47x | 1.96x |
Profitability & Efficiency
ARDT leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.0% | — |
| ROA (TTM)Return on assets | +2.6% | -0.7% |
| ROICReturn on invested capital | +7.5% | -70.1% |
| ROCEReturn on capital employed | +7.9% | -87.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 1.34x | — |
| Net DebtTotal debt minus cash | $1.6B | $11.3B |
| Cash & Equiv.Liquid assets | $710M | $260M |
| Total DebtShort + long-term debt | $2.3B | $11.6B |
| Interest CoverageEBIT ÷ Interest expense | 6.36x | 4.89x |
Total Returns (Dividends Reinvested)
Evenly matched — ARDT and CYH each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARDT five years ago would be worth $6,152 today (with dividends reinvested), compared to $1,902 for CYH. Over the past 12 months, CYH leads with a -11.7% total return vs ARDT's -30.5%. The 3-year compound annual growth rate (CAGR) favors CYH at -6.0% vs ARDT's -15.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +14.4% | -6.6% |
| 1-Year ReturnPast 12 months | -30.5% | -11.7% |
| 3-Year ReturnCumulative with dividends | -38.5% | -16.8% |
| 5-Year ReturnCumulative with dividends | -38.5% | -81.0% |
| 10-Year ReturnCumulative with dividends | -38.5% | -80.3% |
| CAGR (3Y)Annualised 3-year return | -15.0% | -6.0% |
Risk & Volatility
Evenly matched — ARDT and CYH each lead in 1 of 2 comparable metrics.
Risk & Volatility
ARDT is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 1.60x |
| 52-Week HighHighest price in past year | $15.48 | $4.47 |
| 52-Week LowLowest price in past year | $8.07 | $2.38 |
| % of 52W HighCurrent price vs 52-week peak | +63.8% | +64.8% |
| RSI (14)Momentum oscillator 0–100 | 46.6 | 46.4 |
| Avg Volume (50D)Average daily shares traded | 382K | 1.6M |
Analyst Outlook
CYH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ARDT as "Buy" and CYH as "Hold". Consensus price targets imply 34.9% upside for ARDT (target: $13) vs 1.2% for CYH (target: $3).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $13.33 | $2.93 |
| # AnalystsCovering analysts | 12 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.5% |
ARDT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CYH leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
ARDT vs CYH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ARDT or CYH a better buy right now?
For growth investors, Ardent Health Partners, LLC (ARDT) is the stronger pick with 6.
0% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Ardent Health Partners, LLC (ARDT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ARDT or CYH?
On trailing P/E, Community Health Systems, Inc.
(CYH) is the cheapest at 0. 8x versus Ardent Health Partners, LLC at 10. 3x.
03Which is the better long-term investment — ARDT or CYH?
Over the past 5 years, Ardent Health Partners, LLC (ARDT) delivered a total return of -38.
5%, compared to -81. 0% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: ARDT returned -38. 5% versus CYH's -80. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ARDT or CYH?
By beta (market sensitivity over 5 years), Ardent Health Partners, LLC (ARDT) is the lower-risk stock at 1.
40β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 15% more volatile than ARDT relative to the S&P 500.
05Which is growing faster — ARDT or CYH?
By revenue growth (latest reported year), Ardent Health Partners, LLC (ARDT) is pulling ahead at 6.
0% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to -39. 2% for Ardent Health Partners, LLC. Over a 3-year CAGR, ARDT leads at 7. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ARDT or CYH?
Community Health Systems, Inc.
(CYH) is the more profitable company, earning 4. 1% net margin versus 2. 1% for Ardent Health Partners, LLC — meaning it keeps 4. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ARDT leads at 5. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — ARDT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ARDT or CYH more undervalued right now?
Analyst consensus price targets imply the most upside for ARDT: 34.
9% to $13. 33.
08Which pays a better dividend — ARDT or CYH?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is ARDT or CYH better for a retirement portfolio?
For long-horizon retirement investors, Ardent Health Partners, LLC (ARDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding.
Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ARDT: -38. 5%, CYH: -80. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ARDT and CYH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.